SCHEMBL30289457

SCHEMBL30289457

Cn1c(=O)n(C2CCC(=O)NC2=O)c2ccc(CCCCCCC(=O)OC(C)(C)C)cc21

nearest known ligand 0.58

Predicted protein targets (top 3)

geneUniProtsupporting neighboursconfidence
▸ CRBN Q96SW2 20/20 0.58
▸ DDB1 Q16531 19/20 0.58
▸ GSPT1 P15170 1/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL23842395 1.00 CRBN (0.58) CRBNDDB1GSPT1
SCHEMBL23832518 0.99 CRBN (0.59) CRBNDDB1GSPT1
SCHEMBL23832581 0.96 CRBN (0.60) CRBNDDB1GSPT1
SCHEMBL29347188 0.96 CRBN (0.53) CRBNDDB1GSPT1
SCHEMBL29347190 0.95 CRBN (0.54) CRBNDDB1GSPT1
SCHEMBL22526656 0.93 CRBN (0.62) CRBNDDB1GSPT1
SCHEMBL29651793 0.93 CRBN (0.62) CRBNDDB1GSPT1
SCHEMBL21070678 0.92 CRBN (0.57) CRBNDDB1GSPT1
SCHEMBL22526137 0.89 DDB1 (0.58) CRBNDDB1
SCHEMBL31601585 0.88 CRBN (0.52) CRBNDDB1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-4405359-A2 MDM2 DEGRADERS AND USES THEREOF Kymera Therapeutics, Inc. (US) 2024-07-31 — — EP disclosed
WO-2023049790-A2 MDM2 DEGRADERS AND USES THEREOF KYMERA THERAPEUTICS, INC. (US) 2023-03-30 — — WO disclosed
Send feedback